Cannabis Industry 101: Becoming Mainstream and Essential During COVID-19, What Attorneys Should Know

$95.00

CLE credits earned: 1 General Credit (WA 1 Law and Legal)

Cannabis regulatory compliance and risk management present a challenging legal environment for attorneys. In addition to complying with certain ethical considerations, attorneys who advise cannabis clients must understand varying state licensing structures, identify unique risks and appreciate how the state regulated markets operate alongside federal law. This presentation will help attorneys navigate the state/federal dichotomy, understand risks to financial institutions and related reporting requirements, recognize the current basis for most claims and litigation against the cannabis industry, learn the latest updates on the FDA’s regulation of CBD and other cannabinoids, and implement best practices strategies for cannabis-related clients.

Key topics to be discussed:

• Status of cannabis legalization at the state and federal level
• Impact of COVID on the cannabis and CBD industries
• The cannabis claims and litigation experience to date
• Status of the cannabis insurance market
• Status of CBD regulation at the state and federal level
• Ethical considerations for attorneys who advise cannabis clients

Date / Time: December 3, 2020

•   2:00 pm – 3:00 pm Eastern
•   1:00 pm – 2:00 pm Central
•   12:00 pm – 1:00 pm Mountain
•   11:00 am – 12:00 pm Pacific

Choose a format:

•   Live Video Broadcast/Re-Broadcast: Watch Program “live” in real-time, must sign-in and watch program on date and time set above. May ask questions during presentation via chat box. Qualifies for “live” CLE credit.
•   On-Demand Video: Access CLE 24/7 via on-demand library and watch program anytime. Qualifies for self-study CLE credit. On-demand versions are made available 24 hours after the original recording date and are view-able for up to one year.

Select your state to see if this class is approved for CLE credit.

Choose the format you want.

Clear

Original Broadcast Date: July 30, 2020

Ian A. Stewart │ Wilson Elser
Los Angeles

Ian is founder and co-chair of the Cannabis and Hemp Law practice at Wilson Elser, an AmLaw 200 law firm with 900 attorneys in 39 offices in the United States and London. Ian leads a national multi-disciplinary team of lawyers who serve all aspects of the cannabis and hemp industries, as well as financial institutions and insurance companies that service those industries.

Ian works with licensed cannabis operators throughout the country to comply with their obligations under the law and to develop risk management best practices. He advises Fortune 500 companies on risk management involving hemp-derived CBD and the interplay with U.S. food and drug laws. Ian assists insurance companies on cannabis-related underwriting practices and the development of new policy forms. He also works with financial institutions and professional services firms on best practices for operating in a challenging regulatory environment.

Ian has been named to the prestigious Chambers USA 2020 guide in Cannabis Law. He is a member of the Advisory Board of the International Cannabis Bar Association (INCBA) and participates on the Policy Council of the National Cannabis Industry Association (NCIA). Ian is former chair of NCIA’s Finance and Insurance Committee and former vice chair of the California Cannabis Industry Association (CCIA) Insurance Committee. He is one of MG Magazine’s “30 Powerful Cannabis Attorneys You Should Know.” Ian received a 2019 Readers’ Choice Award by JD Supra for his publication on cannabis consumer class actions and received National Law Review’s award as “Go-To Thought Leader 2018” for his publications on cannabis law.

By way of background, Ian has defended complex litigation in state and federal courts for more than 20 years with a focus on practice areas relevant to the cannabis industry, including product liability, complex general casualty, transportation, data privacy and intellectual property litigation. Ian received his B.A. from Washington University in St. Louis, and his JD from Saint Louis University School of Law. He has been with Wilson Elser for the past 20 years.
 
 

Accreditation Policy
myLawCLE seeks accreditation for all programs in all states. (Accreditation for paralegals sought thru NALA and NFPA paralegal associations.) Each attending attorney/paralegal will receive a certificate of completion following the close of the CLE program as proof of attendance. In required states, myLawCLE records attorney/paralegals attendance, in all other states attorney/paralegal is provided with the approved CLE certificate to submit to their state bar or governing association.

    Automatic MCLE Approvals

All myLawCLE CLE programs are accredited automatically either directly or via reciprocity in the following states: AK, AR, CA, CT, FL, HI, ME, MO, MT, ND, NH, NM, NJ, NY, and VT. (AZ does not approve CLE programs, but accepts our certificates for CLE credit.)

    Live Video Broadcasts

Live video broadcasts are new live CLE programs being streamed and recorded for the first time. All of these programs qualify for “Live” CLE credit in all states except NV, OH, MS, IN, UT, PA, GA, SC, and LA —these states require in-person attendance to qualify for “Live” CLE credit.

    “Live” Re-Broadcasts

“Live” Re-broadcasts are replays of previous recorded CLE programs, set on a specific date and time and where the original presenting speakers calls in live at the end of the event to answer questions. This “live” element allows for “live” Re-broadcast CLEs to qualify for “Live” CLE credits in most states. [The following states DO NOT allow for “live” CLE credits on re-broadcast CLEs: NV, OH, MS, IN, UT, PA, GA, SC, and LA]

Reciprocity
Many states allow for credit to be granted on a 1:1 reciprocal basis for courses approved in another mandatory CLE jurisdiction state. This is known as a reciprocity provision and includes the following states: AK, AR, HI, CT, FL, ME, MO, MT, ND, NH, NM, VT, NJ, and NY. myLawCLE does not seek direct accreditation of live webinars or teleconferences in these states.

I. Status of cannabis legalization at the state and federal level 2:00-2:10
II. Impact of COVID on the cannabis and CBD industries 2:10-2:20
III. The cannabis claims and litigation experience to date 2:20-2:30
IV. Status of the cannabis insurance market 2:30-2:40
V. Status of CBD regulation at the state and federal level 2:40-2:50
VI. Ethical considerations for attorneys who advise cannabis clients 2:50-3:00